India, April 9 -- Samsung Electronics and Stanford University have jointly announced a research project with Stanford Medicine to initiate an innovative health solution based on Samsung's obstructive sleep apnea (OSA) feature which has received De Novo - the first of its kind authorization - by the United States Food and Drug Administration (FDA).

In recognition of World Health Day, this project underscores the importance of sleep in overall health by taking further steps in proactive care, beginning with a pioneering study.

Led by professor Robson Capasso as principal investigator and professor Clete Kushida as co-principal investigator, the joint study is designed to explore potential ways to further enhance Samsung's Sleep Apnea feat...